This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. Johnson & Johnson said Tuesday that it plans to spin out its orthopedics business, creating a standalone company that would compete with firms like Stryker and Zimmer Biomet. The healthcare giant said the decision is intended to focus its medtech unit on higher-growth and higher-margin markets. The spinout, which will be called DePuy Synthes, is expected to happen in ...

Group 1: M&A Activity - Papa John's shares increased significantly following a report of a $64 per share bid from Apollo [3] Group 2: Supply Chain Issues - Ford is temporarily cutting production of at least five models due to a fire at a key aluminum supplier's plant [3] Group 3: Banking Sector Earnings - Large-cap banks are expected to report third-quarter earnings this week, with JPMorgan Chase, Citigroup, Goldman Sachs, and Wells Fargo leading the earnings season [4] - Most large-cap banks are anticipated to report year-over-year EPS growth, with Citigroup expected to show the strongest growth among globally important systemic banks [5] - Citizens Financial is projected to have the highest annual EPS growth among regional banks [5] Group 4: Analyst Insights - Bank of America analyst Ebrahim Poonawala is focusing on guidance for net interest income exit rates for Q4, which may influence EPS revisions and stock performance [6] - Morgan Stanley analyst Betsy Graseck favors Citi, Bank of America, Goldman, and JPMorgan based on expectations of strong investment banking fees and trading revenue [6] Group 5: Market Trends - Financial sector EPS growth for Q3 '25 is starting at +14.25%, which is considered a high bar compared to the sector's average of 6% EPS growth since Q1 '22 [7] - The financial sector's performance this week is expected to reflect positively on the U.S. economy, but stock trading patterns post-earnings will be closely monitored [7] Group 6: Other Corporate Developments - Tesla's Cybertruck sales are reportedly falling short of forecasts [8] - Keurig Dr Pepper's stock gained following news of Starboard's stake acquisition [8] - OpenAI has partnered with Broadcom for its first in-house AI chip [8] - Google plans to invest $10 billion in India and $9 billion in South Carolina [8]

U.S. stock futures declined on Tuesday following Monday’s reversal rally. Futures of major benchmark indices were lower.Leading the charge on Monday, Oracle Corp. (NYSE:ORCL) shares jumped more than 5%, while Nvidia Corp. (NASDAQ:NVDA) gained almost 3%. Broadcom Inc. (NASDAQ:AVGO) soared around 10% after OpenAI pledged a $500-billion investment to co-develop 10 gigawatts of custom AI accelerators with the chipmaker. Treasury Secretary Scott Bessent said that the ongoing government shutdown has started to af ...

Core Viewpoint - Johnson & Johnson has been ordered to pay $966 million due to the carcinogenic nature of its talc-based baby powder products, with thousands of lawsuits filed globally since 2010 [1] Summary by Relevant Categories Legal and Financial Implications - The recent ruling adds to the ongoing financial burden on Johnson & Johnson, which has already announced plans to pay $8.9 billion in settlements over the next 25 years [1] - The latest judgment may further increase the total compensation amount that the company is liable for by the deadline of October 2025 [1] Product Safety and Public Health - The lawsuits are centered around the claim that the talc in Johnson & Johnson's baby powder products is linked to cancer, raising significant concerns about product safety and public health [1]

Group 1 - Goldman Sachs Group Inc. is expected to report quarterly earnings of $11.00 per share on revenue of $14.10 billion [2] - JPMorgan Chase & Co. is projected to post quarterly earnings of $4.84 per share on revenue of $45.39 billion [2] - Johnson & Johnson is anticipated to report quarterly earnings of $2.75 per share on revenue of $23.74 billion [2] - Citigroup Inc. is expected to report quarterly earnings of $1.90 per share on revenue of $21.09 billion [2] Group 2 - Polaris Inc. has entered into a definitive agreement to sell a majority stake in Indian Motorcycle to Carolwood LP, expected to close in Q1 2026 [2] - Following the announcement, Polaris shares surged 11.1% to $68.19 in after-hours trading [2]

Market Overview - Japan's Nikkei index fell by 2.2% or 1061 points to 47,027 after a national holiday [2][4] - The Hang Seng index in Hong Kong decreased by 0.1% to 25,839, while Shanghai's Composite index increased by 0.2% to 3,897.56 [2][4] - South Korea's Kospi index saw a slight increase of 0.02% to 3,585 [2][4] U.S.-China Relations - President Trump reassured that the U.S. wants to help China, stating that Xi Jinping "doesn't want Depression for his country" [2][4] - Trump's comments followed a turbulent week for markets, including his criticism of China and threats of higher tariffs [2][4] - Despite tough rhetoric, Trump indicated a potential meeting with Xi Jinping later this month, leaving trade talks uncertain [2][4] Stock Performance - Broadcom experienced a significant gain of 9.9% after announcing a partnership with OpenAI to develop AI accelerators for ChatGPT [3][4] - Fastenal reported a 7.5% drop, marking the largest loss in the S&P 500 due to slightly weaker-than-expected quarterly profits [3][4] - Investors are focusing on the upcoming earnings season, with major companies like JPMorgan Chase, Johnson & Johnson, and United Airlines set to report [3][4] Commodities and Currency - U.S. crude oil prices increased by 20 cents to $59.69 per barrel, while Brent crude rose by 21 cents to $63.53 per barrel [3][4] - In currency markets, the dollar fell to 152.13 Japanese yen from 152.29 yen, while the euro strengthened to $1.1581 from $1.1569 [3][4]

Company Overview - Tuco Kids is a startup founded in 2023, headquartered in Bengaluru, focusing on kids' beauty products that cater to children aged 3 to 15 [9][10][12] - The company has secured a total of $6 million in funding, with $4 million raised in a recent Series A round, backed by investors such as RTP Global and Fireside Ventures [6][11] Market Opportunity - The global market for kids' beauty products is valued at $1,387 million and is projected to grow at an annual average of 6.9%, reaching $2,365.36 million by 2033 [2] - In India, kids aged 10 to 18 years hold a 15-20% share of the $5 billion beauty and personal care market, which is expected to exceed $28 billion by 2030 [2] Product Offering - Tuco Kids offers products in the affordable-premium range of INR 199 to INR 699, with over 35 SKUs including skincare, haircare, and beauty items like kajal and lip tints [20][22] - The brand emphasizes natural ingredients such as turmeric, saffron, and ritha, aiming to provide safe and effective products for children [18][19] Competitive Landscape - The market is currently dominated by established brands like Johnson & Johnson and Himalaya, but Tuco Kids aims to fill the gap for products specifically designed for older children [5][12] - Tuco Kids competes with other emerging brands like Whimsy and Mamaearth, focusing on sustainability and natural formulations [19][30] Growth Strategy - The company has experienced significant growth, reportedly increasing tenfold since November and maintaining a double-digit month-on-month growth rate [21][22] - Tuco Kids plans to expand its offline presence in Tier I cities and aims to achieve an annual recurring revenue (ARR) of INR 100 crore within the next 18 months [32] Marketing Approach - Influencer marketing plays a crucial role in Tuco Kids' strategy, targeting the growing influence of young consumers and their purchasing decisions [30][31] - The brand engages in digital storytelling and partnerships with parenting creators to enhance brand awareness and trust [31]

Market Performance - The Dow gained 587 points (+1.29%), the S&P 500 added 102 points (+1.56%), the Nasdaq rose 490 points (+2.21%), and the Russell 2000 increased by 66 points (+2.79%) following a significant sell-off on Friday [1] AI and Quantum Computing Stocks - Investors looking for entry points into AI and Big Tech drove quantum computing stocks higher, with Rigetti (RGTI) up 25% and D-Wave (QBTS) up 23% [2] - Shares of U.S. Antimony (UAMY) and Critical Metals (CRML) surged by 36.8% and 55.4%, respectively, due to ongoing discussions about rare earth minerals [2] Broadcom and OpenAI Partnership - Broadcom (AVGO) entered a deal with OpenAI to produce approximately 10 gigawatts of custom chips valued at around $10 billion, resulting in a 9.9% increase in Broadcom's shares [3] Upcoming Earnings Reports - Major banks are set to report Q3 earnings, with JPMorgan expected to see a 10.5% growth in earnings and 5.2% in revenues, Citigroup anticipated to post 21.2% earnings growth and 3.7% revenue growth, and Wells Fargo projecting 2% earnings growth and 4% revenue growth [4] - Goldman Sachs (GS) and BlackRock (BLK) will also release their quarterly earnings reports, along with Johnson & Johnson (JNJ) and Domino's Pizza (DPZ) [5]

Core Insights - Protagonist Therapeutics (PTGX) shares increased by 30% following reports of acquisition interest from Johnson & Johnson (J&J) [1] - Ongoing discussions between PTGX and J&J are noted, but specific deal terms remain undisclosed [1] - The potential acquisition is seen as a strategic move for J&J to offset declining sales from its drug Stelara [8] Company Overview - Protagonist Therapeutics is a clinical-stage company based in California, focusing on developing novel peptides [2] - The lead candidate, icotrokinra (JNJ-2113), is under FDA review for plaque psoriasis and is being developed for various immunology diseases [2] - PTGX has an existing partnership with J&J, which holds exclusive rights to develop icotrokinra in phase II studies and beyond [3] Financial Performance - Year-to-date, PTGX stock has surged by 125%, significantly outperforming the industry growth of 7% [4] Strategic Implications - J&J's interest in PTGX is driven by the need to compensate for a nearly 43% decline in Stelara sales due to generic competition [8] - The acquisition could enhance J&J's portfolio in immunology and hematology, diversifying revenue streams [9] Industry Context - The pharmaceutical sector continues to pursue strategic acquisitions despite macroeconomic challenges [11] - Recent notable transactions include Pfizer's $4.9 billion acquisition of Metsera and Roche's $3.5 billion acquisition of 89bio, indicating ongoing interest in innovative biotech assets [12][13][15]

Market Overview - U.S. equities experienced a significant rebound on October 13, 2025, recovering from substantial losses due to improved investor sentiment following President Trump's softened trade rhetoric towards China [1][3] - Major U.S. stock indexes, including the S&P 500, Nasdaq Composite, and Dow Jones Industrial Average, all posted robust gains in afternoon trading, with the S&P 500 up 1.6%, Nasdaq up 2.1%, and Dow up 1.3% [2] Sector Performance - The technology sector led the market recovery, with the Technology Select Sector SPDR (XLK) showing significant gains, while other sectors such as Materials (XLB), Energy (XLE), Consumer Discretionary (XLY), Communication Services (XLC), Financial (XLF), and Industrial (XLI) also registered advances [4] - The Consumer Staples Select Sector SPDR (XLP) was the only sector in negative territory, down approximately 0.22%, as investors shifted towards more cyclical sectors [5] Upcoming Market Events - The U.S. earnings season is set to begin, with major banks like JPMorgan Chase scheduled to report quarterly results, alongside other notable companies such as Johnson & Johnson and United Airlines [6] - The ongoing U.S. government shutdown is delaying the release of key economic data, including inflation figures and retail sales data, which could introduce uncertainty for the Federal Reserve's monetary policy decisions [7] Corporate Developments - Broadcom shares surged approximately 10% following a collaboration announcement with OpenAI to design custom AI accelerators, highlighting strong investor interest in the AI sector [12] - Other chipmakers, including Advanced Micro Devices and Micron Technology, also saw gains of 3.4% and 4.9% respectively, while Nvidia gained close to 3% [12] - Fastenal shares fell between 4.8% and 6.4% after reporting third-quarter profits that narrowly missed analysts' expectations [12] - HCL Technologies is set to announce its Q2 FY26 results, with investors focused on management's commentary regarding deal pipelines and demand outlook [12] - Avenue Supermarts reported a steady Q2 FY26 performance, with a nearly 4% year-on-year increase in consolidated net profit and a 15.5% rise in revenue [12] - Bharat Petroleum Corporation Limited announced a strategic partnership with Reliance BP Mobility Ltd to expand its city gas distribution and compressed natural gas network [12]